Ledger.Open graph →
SEC Form D · filed July 6, 2023

Actym Therapeutics, Inc

Offering
$27.5M
Sold
$11.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Christopher D. Thanos · Berkeley, CAExec · DirectorJulie D. Cherrington · Berkeley, CADirectorKanad D. Das · Berkeley, CADirectorBenjamin D. Chen · Berkeley, CADirectorRon D. Mazumder · Berkeley, CADirectorKanad D. Das · Berkeley, CADirectorChristopher D. Thanos · Berkeley, CAExec · DirectorBenjamin D. Chen · Berkeley, CADirectorRon D. Mazumder · Berkeley, CADirectorJulie D. Cherrington · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗